Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT): What Happened After COVID-19 Vaccination?
Introduction
During the global rollout of COVID-19 vaccines in 2021, a rare but serious medical condition was reported in some individuals after vaccination. The condition, called Vaccine‑Induced Immune Thrombocytopenia and Thrombosis (VITT), involved unusual blood clots along with low platelet levels.
Most reported cases were linked to adenovirus-vector vaccines such as:
-
AstraZeneca COVID‑19 Vaccine
-
Johnson & Johnson COVID‑19 Vaccine
Understanding this rare complication became an important scientific challenge and eventually revealed important insights into how the immune system works.
For UPSC aspirants, this topic is relevant for GS-III (Science & Technology, Health) and Prelims biotechnology questions.
What is VITT?
VITT is a rare condition where the body:
-
forms blood clots
-
experiences low platelet counts
This unusual combination is dangerous because platelets normally help blood clot during injuries.
In VITT:
-
platelets are activated excessively
-
clots form in unusual locations (brain veins, abdominal vessels)
The incidence was very rare — approximately 3–10 cases per million vaccinated people.
Role of Platelet Factor 4 (PF4)
Researchers discovered that patients with VITT were producing antibodies against a human protein called:
Platelet Factor 4 (PF4).
PF4 normally helps regulate blood clotting.
However, in VITT:
-
Antibodies bind to PF4
-
The PF4-antibody complex activates platelets
-
Platelets form clots and get consumed
-
Platelet counts fall in the blood
This explains the combination of clotting and low platelets.
How COVID-19 Vaccines Work
Vaccines train the immune system by exposing it to a harmless version of a pathogen.
The target for COVID-19 vaccines was the SARS‑CoV‑2 Spike Protein.
Different vaccines used different technologies.
Two Main Types of COVID-19 Vaccine Technology
1. mRNA Vaccines
Examples:
-
Pfizer‑BioNTech COVID‑19 Vaccine
-
Moderna COVID‑19 Vaccine
These vaccines deliver messenger RNA (mRNA) directly into cells.
Process:
-
mRNA enters cell cytoplasm
-
Ribosomes read the instructions
-
Spike protein is produced
-
Immune system learns to recognise it
mRNA never enters the nucleus and is quickly destroyed.
2. Adenovirus-Vector Vaccines
Examples:
-
AstraZeneca COVID‑19 Vaccine
-
Johnson & Johnson COVID‑19 Vaccine
These vaccines use a harmless virus (adenovirus) as a delivery vehicle.
Steps:
-
Modified adenovirus carries DNA instructions
-
DNA enters the cell nucleus
-
Cell produces mRNA
-
Spike protein is produced
This method efficiently delivers genetic instructions into cells.
Why Did VITT Occur?
Recent research identified the trigger.
Inside the adenovirus is a protein called:
Adenovirus Protein VII
A small part of this protein resembles PF4.
Because of this similarity:
-
Immune system creates antibodies against the viral protein
-
In rare cases, antibodies mistakenly bind to PF4
-
This causes platelet activation and clot formation
This process is known as molecular mimicry, where immune responses mistakenly attack similar-looking body proteins.
Genetic Susceptibility
Researchers also found that many affected patients shared specific variants of an antibody gene called:
IGLV3‑21
A small mutation in these antibodies increased their ability to bind PF4 strongly.
Thus, VITT occurred only in people with rare genetic and immunological conditions.
Why the Discovery is Important
Understanding the mechanism behind VITT helps scientists:
-
design safer vaccines
-
modify adenovirus vectors
-
identify individuals at risk
It also reassures the public that such events are extremely rare.
Importance of Adenovirus Vaccines
Despite this rare complication, adenovirus vaccines played a crucial role in global vaccination programs.
They are important because they:
-
are cheaper to produce
-
are easy to store
-
helped vaccinate millions in developing countries
Relevance for UPSC
Prelims
-
Vaccine technology (mRNA vs viral vector)
-
Antibodies and immune response
-
Biotechnology applications
GS-III
-
Biotechnology and health security
-
Vaccine development
-
Public health and pandemic response
Conclusion
The discovery of the mechanism behind VITT represents a major scientific breakthrough. It shows how complex interactions between genetics, immunity, and vaccine design can occasionally produce unexpected effects.
Importantly, the research also demonstrates how science continuously improves medical technologies. By identifying the role of adenovirus protein VII and specific antibodies, scientists can now design even safer vaccines in the future.
No comments:
Post a Comment